Research Topics
Species | R B FreemanSummaryAffiliation: Tufts-New England Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytesRandy J Chandler
National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
BMC Med Genet 8:24. 2007....
Survival benefit: quality versus quantity and trade-offs in developing new renal allocation systemsR B Freeman
Division of Transplantation, Tufts-New England Medical Center, Box 40750 Washington Street, Boston, MA, USA
Am J Transplant 7:1043-6. 2007
Transplantation for hepatocellular carcinoma: The Milan criteria and beyondRichard B Freeman
Division of Transplant Surgery, Tufts New England Medical Center, Boston, MA 02111, USA
Liver Transpl 12:S8-13. 2006..5. Liver allocation for HCC candidates in the context of increasing HCC prevalence requires better and evidence-based prioritization policies...
MELD/PELD: one year laterR B Freeman
Department of Surgery, Division of Transplantation, New England Medical Center Tufts University School of Medicine, Boston, Massachusetts 02111, USA
Transplant Proc 35:2425-7. 2003..Although there are many areas for improvement, which will be addressed in future refinements, the new US liver allocation plan has provided a more objective, patient-specific system to better rank waiting liver transplant candidates...
Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN databaseRichard B Freeman
Division of Transplantation, Department of Surgery, Tufts New England Medical Center, Boston, MA 02111, USA
Liver Transpl 12:1504-11. 2006..In conclusion, current imaging requirements for RS prior to liver transplantation are unacceptably inaccurate. Future policy should require more accurate modalities or combinations of techniques...
Improving liver allocation: MELD and PELDRichard B Freeman
Tufts New England Medical Center, Boston, MA, USA
Am J Transplant 4:114-31. 2004..Children younger than 2 years, however, still have a considerably higher rate of death on the waiting list than adults. A limited definition of ECD livers suggests that they are used more frequently for patients with lower MELD scores...
Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised hostRichard B Freeman
Tufts New England Medical Center, Division of Transplant Surgery, Box 40, 750 Washington Street, Boston, MA 02111, USA
Expert Opin Pharmacother 5:2007-16. 2004..The high bioavailability and convenient dosing formulation make valganciclovir an attractive option for these indications...
Liver allocation: the intent-to-treat approachRichard B Freeman
Department of Surgery, Division of Transplantation, Tufts-New England Medical Center, Boston, MA 02111, USA
Transpl Int 19:270-4. 2006
Excellent liver transplant survival rates under the MELD/PELD systemR B Freeman
Division of Transplant Surgery, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Transplant Proc 37:585-8. 2005..Although recipients with MELD scores in the highest quartile have reduced survival compared with other quartiles, their 1-year survival rate is acceptable when their extreme risk of dying without a transplant is taken into consideration...
MELD: the holy grail of organ allocation?Richard B Freeman
Division of Transplant Surgery, Tufts New England Medical Center, P O Box 40, 750 Washington Street, Boston, MA 02111, USA
J Hepatol 42:16-20. 2005
The impact of the model for end-stage liver disease on recipient selection for adult living liver donationRichard B Freeman
Division of Transplant Surgery, Tufts-New England Medical Center, Boston, MA 02111, USA
Liver Transpl 9:S54-9. 2003
The model for end-stage liver disease comes of ageRichard B Freeman
Division of Transplant Surgery, Tufts New England Medical Center, Box 40, 750 Washington Street, Boston, MA 02111, USA
Clin Liver Dis 11:249-63. 2007....
Model for end-stage liver disease (MELD) for liver allocation: a 5-year score cardRichard B Freeman
Division of Transplantation, Tufts-New England Medical Center, Boston, MA, USA
Hepatology 47:1052-7. 2008
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipientsRichard B Freeman
New England Medical Center of Transplant Surgery, Boston, MA 2 Mayo Clinic, Rochester, MN 02111, USA
Transplantation 78:1765-73. 2004..Cytomegalovirus (CMV) D+/R- solid-organ transplant (SOT) recipients carry increased risk of developing CMV disease; however, other risk factors in these patients have not been delineated...
Liver and intestine transplantation in the United States, 1997-2006R B Freeman
Tufts New England Medical Center, Division of Transplant Surgery, Boston, MA, USA
Am J Transplant 8:958-76. 2008..Survival rates have increased over time. Small children waiting for intestine grafts continue to have the highest waiting list mortality...
"Transplant tourism" in the United States?Richard B Freeman
Division of Transplantation, Tufts New England Medical Center, Boston, MA 02111, USA
Transplantation 84:1559-60. 2007
Waiting list removal rates among patients with chronic and malignant liver diseasesR B Freeman
Division of Transplantation, Department of Surgery, Tufts-New England Medical Center, Boston, Massachusetts, USA
Am J Transplant 6:1416-21. 2006..Liver transplant candidates with HCC may be prioritized using a risk score analogous to the MELD score...
Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policyRussell H Wiesner
William J von Liebig Transplant Center, Mayo Clinic, 200 First Street, SW, Rochester, Minnesota 55905, USA
Gastroenterology 127:S261-7. 2004..It is hoped that through continued data collection and assessment, a consensus can be reached to further optimize the use of deceased donors in HCC recipients...
Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selectionRichard B Freeman
Tufts-New England Medical Center; Tufts University School of Medicine, Boston, MA, USA
Liver Transpl 10:S2-3. 2004
Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting timeR B Freeman
New England Medical Center Tufts University School of Medicine, Division of Transplant Surgery, Box 40, 750 Washington St, Boston, MA 02111, USA
Liver Transpl 7:173-8. 2001..We conclude that a continuous medical urgency score system allocates donor livers much more fairly to those in medical need and reduces waiting list mortality without sacrificing efficacy...
Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysisS J Cheng
New England Medical Center, Tufts University School of Medicine, 750 Washington St, PO Box 302, Boston, MA 02111, USA
Transplantation 72:861-8. 2001..CONCLUSIONS: Living-donor liver transplantation should confer a substantial survival advantage for patients with compensated cirrhosis and non-resectable early stage hepatocellular carcinoma...
Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policyR B Freeman
Department of Surgery, Division of Transplantation, Tufts University School of Medicine New England Medical Center, Boston, MA 02111, USA
Liver Transpl 6:543-52. 2000..Waiting time and center transplant rates should not influence liver allocation policy...
Results of the first year of the new liver allocation planRichard B Freeman
Tufts University School of Medicine, New England Medical Center, Division of Transplantation, Boston, MA 02111, USA
Liver Transpl 10:7-15. 2004....
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipientsM D Pescovitz
Transplantation Section, Department of Surgery, and Department of Microbiology Immunology, Indiana University, Indianapolis, Indiana 42602, USA
Antimicrob Agents Chemother 44:2811-5. 2000..Oral VGC delivers systemic GCV exposure equivalent to that of standard oral GCV (at 450 mg) or i.v. GCV (at 900 mg of VGC). VGC has promise for effective CMV prophylaxis or treatment with once-daily oral dosing in transplant recipients...
Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membershipJ R Rodrigue
The Transplant Center and Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA
Am J Transplant 9:2172-6. 2009..Overall, there is strong support within the ASTS membership for changes to NOTA that would permit the implementation and careful evaluation of indirect, government-regulated strategies to increase organ donation...
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USAKim M Olthoff
Department of Surgery, Division of Transplantation, University of Pennsylvania, Philadelphia, PA, USA
Liver Transpl 10:A6-22. 2004..Recommendations for the transplant community, based on the analysis of the MELD data, were discussed and are presented in the summary document...
Moving kidney allocation forward: the ASTS perspectiveR B Freeman
Tufts Medical Center, Boston, MA, USA
Am J Transplant 9:1501-6. 2009..We offer alternative policy options to address some of the unmet needs and issues that were brought to light during this interesting process...
Cytokine gene promoter polymorphisms and mortality in acute renal failureBertrand L Jaber
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Cytokine 25:212-9. 2004..Although cytokines play a pivotal role in the inflammatory responses that mediate the severity of acute renal failure (ARF), the importance of pro- and anti-inflammatory cytokine gene promoter polymorphisms has been unexplored...
Aerobic capacity is associated with 100-day outcome after hepatic transplantationScott K Epstein
Department of Medicine, New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA
Liver Transpl 10:418-24. 2004..Identification of predictors of survival at the time of listing for transplantation might lead to better resource allocation...
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patientsWalter K Kremers
The William J von Liebig Transplant Center, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
Hepatology 39:764-9. 2004..68). In conclusion, liver allocation within the Status 1 designation may need to be further stratified by diagnosis, and MELD score may be useful for prioritizing FHF-NA candidates...
The new liver allocation system: moving toward evidence-based transplantation policyRichard B Freeman
Department of Surgery, Tufts New England Medical Center Tufts University School of Medicine, Boston, MA, USA
Liver Transpl 8:851-8. 2002..Application of such risk models provides an evidenced-based approach on which to base further refinements and improve the model...
The impact of variation in donation after cardiac death policies among donor hospitals: a regional analysisJ Y Rhee
Transplantation, Tufts Medical Center, Boston, MA, USA
Am J Transplant 11:1719-26. 2011..Our regional analysis highlights the high degree of variability of hospital DCD policies, which may contribute to misunderstanding and confusion among providers and patients that may influence acceptance of this mode of donation...
Predicting the probability of progression-free survival in patients with small hepatocellular carcinomaSteve J Cheng
Department of Medicine, Division of Clinical Decision Making, New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA
Liver Transpl 8:323-8. 2002..To ensure that these patients have a fair opportunity to receive a cadaveric organ, HCC-specific scores predicted by our model could be added to MELD scores of patients with HCC...
Organ donationJason Rhee
Division of Transplantation, Tufts Medical Center, Boston, Massachusetts, USA
Semin Liver Dis 29:19-39. 2009..As the demand for organs rises relentlessly, more research must be devoted to understanding how to make the marginal donor organs function better...
Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantationKaren J Ho
Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Transplantation 85:1588-94. 2008..We hypothesized that donor postextubation parameters, including duration and severity of hemodynamic instability or hypoxia might be a better predictor of subsequent graft function...
Transplantation risks and the real world: what does 'high risk' really mean?R B Freeman
Division of Transplantation, Department of Surgery, Tufts Medical Center, Boston, MA, USA
Am J Transplant 9:23-30. 2009..These comparisons can be helpful for informing patients and guiding future policy development...
Fetal cells participate over time in the response to specific types of murine maternal hepatic injuryK Khosrotehrani
Division of Genetics, Department of Pediatrics, Tufts New England Medical Center, Boston, MA 02111, USA
Hum Reprod 22:654-61. 2007..Our objective was to determine whether fetal cells participate in the response to specific murine post-partum hepatic injuries...
Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipientsRobert M Merion
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
Am J Transplant 4:1792-7. 2004....
Redrawing organ distribution boundaries: results of a computer-simulated analysis for liver transplantationRichard B Freeman
Department of Surgery, Division of Transplantation, New England Medical Center Tufts University School of Medicine, Boston, MA 02111, USA
Liver Transpl 8:659-66. 2002..Enlarging liver distribution units likely will result in significant shifts in organs across current OPO boundaries, which will have a significant impact on the activity of many transplant centers...
Diagnosing hepatocellular carcinoma: a virtual realityRichard B Freeman
Division of Transplantation, Tufts University School of Medicine, New England Medical Center, Boston, MA 02111, USA
Liver Transpl 8:762-4. 2002
Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysisManish G Amin
Division of Gastroenterology and Institute for Clinical Research and Health Policy Studies, Tufts New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA
Liver Transpl 10:1468-75. 2004..At less advanced MELD scores, the survival benefit depends on the risk of PGF associated with the ECD organ...
Characterization of the withdrawal phase in a porcine donation after the cardiac death modelJ Y Rhee
Division of Transplantation, Department of Surgery, Tufts Medical Center, Boston, MA, USA
Am J Transplant 11:1169-75. 2011..Early histologic evidence suggests that there is severe hepatocyte and biliary cell disruption in our DCD model. Further research using this model may provide a deeper understanding of the pathophysiology of the DCD liver...
The 'indirect' effects of cytomegalovirus infectionR B Freeman
Division of Transplantation, Tufts Medical Center, Boston, MA, USA
Am J Transplant 9:2453-8. 2009..This review focuses on the immunosuppressive and inflammatory mechanisms that have been attributed to CMV and will relate them to some of the clinical sequellae that have been associated with the indirect effects of CMV infection...
Impact of donor infections on outcome of orthotopic liver transplantationMichael Angelis
Division of Transplantation, Tufts-New England Medical Center, Boston, MA 02111, USA
Liver Transpl 9:451-62. 2003..These issues are critically important to maximize the use of donated organs but also minimize recipient morbidity and graft dysfunction...
Risk factors associated with the development of skin cancer after liver transplantationAbigail B Mithoefer
Division of Transplantation, New England Medical Center/Tufts University School of Medicine, Boston, MA 02111, USA
Liver Transpl 8:939-44. 2002..Recipients with identified risk factors may be candidates for prophylactic treatment and should be followed more intensively after liver transplantation...
The survival benefit of liver transplantationRobert M Merion
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
Am J Transplant 5:307-13. 2005..With 1 year post-transplant follow-up, patients at lower risk of pre-transplant death do not have a demonstrable survival benefit from liver transplant...
Liver transplantation for hepatocellular carcinoma: racial disparities?Richard B Freeman
Am J Gastroenterol 103:128-30. 2008..The cause of these results, however, remains obscure with the need for a more in-depth confirmation of these findings readily apparent...
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donorBruce R Rosengard
Harvard Medical School, Massachusetts General Hospital, Boston 02114, USA
Am J Transplant 2:701-11. 2002
Optimizing the use of donated cadaver livers: analysis and policy development to increase the application of split-liver transplantationJean C Emond
Center for Liver Diseases and Transplantation, New York Presbyterian Hospital, New York, NY 10032, USA
Liver Transpl 8:863-72. 2002..This article details the data reviewed by the liver committee and their recommendations on policy development for the expanded application of split-liver transplantation...
Mathematical models and behavior: assessing delta MELD for liver allocationRichard B Freeman
Am J Transplant 4:1735-6. 2004
Regional variations in peer reviewed liver allocation under the MELD systemHector Rodriguez-Luna
Transplantation Medicine, Mayo Clinic Hospital, Phoenix, Arizona, USA
Am J Transplant 5:2244-7. 2005..9%, p<0.0001). Demographics did not differ among regions requesting non-REDs.Widespread regional variations exist in the handling of requests for non-REDs. These variations point to the need for reform to standard exception criteria...
Mortality risk, behavior, and pediatric liver allocationRichard B Freeman
Liver Transpl 12:12-5. 2006
MELD and liver allocation: continuous quality improvementRichard B Freeman
Hepatology 40:787-9. 2004
Mortality risk versus other endpoints: who should come first on the liver transplant waiting list?Richard B Freeman
Liver Transpl 10:675-7. 2004
Liver allocation for HCC: a moving targetRichard B Freeman
Liver Transpl 10:49-51. 2004
In pursuit of the ideal liver allocation modelRichard B Freeman
Liver Transpl 8:799-801. 2002
Liver and intestine transplantationJohn P Roberts
University of California San Francisco, San Francisco, CA, USA
Am J Transplant 3:78-90. 2003
Justice, administrative law, and the transplant clinician: the ethical and legislative basis of a national policy on donor liver allocationNeal R Barshes
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA
J Contemp Health Law Policy 23:200-30. 2007
MELD and the quality of lifeRichard B Freeman
Liver Transpl 11:134-6. 2005
Predicting the future?Richard B Freeman
Liver Transpl 13:1503-5. 2007
Research Grants
- Liver Transplantation for Hepatocellular CarcinomaRichard Freeman; Fiscal Year: 2005..Furthermore, these analyses will serve to support future developments of prospective clinical trials. ..
